We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $9.71B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.5B
AUM Growth
-$96.1M
Cap. Flow
+$411M
Cap. Flow %
4.83%
Top 10 Hldgs %
34.38%
Holding
534
New
8
Increased
456
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$162M
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$41.2M
3
NVDA icon
NVIDIA
NVDA
+$33.2M
4
UBS icon
UBS Group
UBS
+$19.4M
5
AAPL icon
Apple
AAPL
+$16.9M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$17.1M
2
BDX icon
Becton Dickinson
BDX
+$8.94M
3
SLB icon
SLB Ltd
SLB
+$7.67M
4
GIB icon
CGI
GIB
+$4.75M
5
AMAT icon
Applied Materials
AMAT
+$3.24M

Sector Composition

Rank Sector Weight
1 Technology 30.92%
2 Financials 13.2%
3 Healthcare 11.8%
4 Consumer Discretionary 10.12%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGG icon
526
Graco
GGG
$13.5B
$141K ﹤0.01%
1,671
+39
+2% +$3.45K
OTEX icon
527
Open Text
OTEX
$6.23B
$136K ﹤0.01%
6,142
BIIB icon
528
Biogen
BIIB
$30.5B
$110K ﹤0.01%
+600
New +$111K
WIX icon
529
WIX.com
WIX
$2.55B
$64.4K ﹤0.01%
715
DHI icon
530
D.R. Horton
DHI
$40.8B
$52.3K ﹤0.01%
381
+9
+2% +$1.36K
J icon
531
Jacobs Solutions
J
$16.9B
$50.9K ﹤0.01%
+400
New +$54.4K
FG icon
532
F&G Annuities & Life
FG
$3.87B
$11.5K ﹤0.01%
455
+13
+3% +$339
CYBR
533
DELISTED
CyberArk
CYBR
-1,025
Closed -$457K
AMRZ
534
Amrize Ltd
AMRZ
$28.4B
-28,686
Closed -$1.58M

Similar funds

ASR Vermogensbeheer's Q1 2026 Portfolio in Review

As of Q1 2026, ASR Vermogensbeheer held 534 positions worth $8.5B, down 1.1% from $8.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer deployed $411M of net new capital in Q1 2026, opening 8 new positions and adding to 456 existing holdings. Its largest new stake was AstraZeneca: 841,921 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17.1M trimmed.

  • ASR Vermogensbeheer's largest Q1 2026 buy was AstraZeneca: 841,921 shares worth $163M.
  • ASR Vermogensbeheer added most to NVIDIA in Q1 2026, an estimated $33.2M increase.
  • ASR Vermogensbeheer's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $17.1M.
  • ASR Vermogensbeheer fully exited Amrize Ltd in Q1 2026, selling an estimated $1.58M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $8.5B portfolio in Q1 2026.
  • ASR Vermogensbeheer opened 8 new positions and closed 2 in Q1 2026.
  • ASR Vermogensbeheer's portfolio value fell 1.1% quarter-over-quarter to $8.5B.

Based on ASR Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.